Autopsy study links prostate cancer to single rogue cell
One cell…one initial set of genetic changes - that's all it takes to begin a series of events that lead to metastatic cancer. Now, Johns Hopkins experts have tracked how the cancer process began in 33 men with prostate cancer who died of the disease. Culling information from autopsies, their study points to a set of genetic defects in a single cell that are different for each person's cancer. "These were not your average autopsies," says pathologist G. Steven Bova, M.D., assistant professor of pathology at Johns Hopkins. "We dissected every bit of tumor - in the primary and metastatic sites - and recorded exactly where each piece of tissue came from, analyzed it, and databased the findings." In total, Bova estimates that he and his colleagues examined 150,000 slides and 30,000 blocks of tissue.
The study took 14 years to complete, and part of the challenge was in finding men living with prostate cancer who would agree to have their body autopsied immediately after they died. "Many of the men were motivated to join the study in hopes of leaving some legacy that might lead to cures for this cancer," says Bova, who holds secondary appointments in the departments of pathology, genetic medicine, health sciences informatics, oncology, and urology at Johns Hopkins.
"Much is unclear and appears chaotic about how cancer spreads, but analyzing genetic markers allows us to trace its roots backward, somewhat like ancestry," says Bova. Findings from the study were published online April 12 in Nature Medicine.
Clues to finding the genetic culprit for cancer spread are hidden in the changes that occur in a cell's DNA, the alphabetical code made up of chemicals that guide the everyday life of a cell. Cancers are caused by alterations in DNA code that occur in a variety of ways: making errors in the nucleotide alphabet through mutations, changing the balance of chemicals attached to the on/off switches of genes, and altering the number of gene copies in a cell. When the number of gene copies is disrupted in a cell beyond the customary two copies inherited from each parent, a gene's function can be damaged. This process, called copy number variation, can set the stage for unchecked cell growth and spread, a hallmark of cancer.
For this study, the investigators scanned genes spanning the whole genome in the autopsy samples looking for areas of copy number variation. They did this by attaching the DNA to special silicon chips, and then photographed them with a computer program that produces a report with varying colors representing the amount of DNA in the sample.
The scientists compared the patterns of gains and losses in tissue samples from multiple metastatic sites in 29 of the men. Unique copy number changes were identified, as well as ones that were shared between multiple metastatic sites in each man and with other men in the study.
For example, in several men, the investigators found cells in different areas of metastasis that contained missing chunks of DNA in one common region of the genome. The exact location of the DNA loss was different for each man, but all occurred in the same DNA region. "Each person has a different set of defects that contributes to the cancer," explains Bova.
Metastatic sites develop from cancer cells that break off of the primary cancer. If cancer cells at more than one metastatic site carry a common set of nonrandom genetic defects, it is likely that these cells are derived from a single parent cell, says Bova. Tissue samples from 14 of the 33 men were studied at the highest available resolution, and all showed common genetic patterns across metastatic sites, suggesting a single cell source for their cancer.
Bova says that future studies will help determine whether the common set of changes shared by the various metastatic sites arose in a single "big bang" in the prostate or if the changes accumulated more slowly over time.
Bova says that such autopsy studies of metastatic cancer can provide a molecular catalogue of cellular defects specific to individuals and general groups. The findings, he says, could help narrow the focus of research and guide personalized cancer therapy.
Source: Johns Hopkins Medical Institutions
Articles on the same topic
- Statins alter prostate cancer patients' PSA levelsTue, 28 Apr 2009, 19:50:15 UTC
- Vitamin E, selenium and soy in combination does not prevent prostate cancerSun, 26 Apr 2009, 13:25:21 UTC
- Men treated for localized prostate cancer could benefit from pomegranate juice consumptionSun, 26 Apr 2009, 13:25:18 UTC
- Major statin study reveals several important findings for reducing prostate cancer and diseaseSun, 26 Apr 2009, 5:38:57 UTC
- Statins may exert influence on prostate cancer growth by reducing inflammationSun, 26 Apr 2009, 4:30:29 UTC
- MRI: Effective tool for determining pathologic stage of prostate cancerThu, 23 Apr 2009, 15:58:24 UTC
- New drug shows promise in treating drug-resistant prostate cancerFri, 10 Apr 2009, 14:24:39 UTC
- Gene fusion discovery may lead to improved prostate cancer testThu, 9 Apr 2009, 21:08:17 UTC
- Drug shows activity in men with advanced prostate cancerWed, 8 Apr 2009, 18:51:56 UTC
- New medications show promise in treating drug-resistant prostate cancerTue, 7 Apr 2009, 19:50:19 UTC
- A potential new target for treatment of hormone refractory prostate cancerMon, 6 Apr 2009, 16:22:28 UTC
Other sources
- Statins Alter Prostate Cancer Patients' PSA Levelsfrom Science DailyWed, 29 Apr 2009, 16:21:05 UTC
- Study bolsters hopes for prostate cancer vaccine rejected by FDAfrom LA Times - ScienceWed, 29 Apr 2009, 7:14:16 UTC
- Statins alter prostate cancer patients' PSA levelsfrom PhysorgTue, 28 Apr 2009, 19:49:04 UTC
- Prostate cancer vaccine extends survival in studyfrom PhysorgTue, 28 Apr 2009, 18:42:10 UTC
- 3-D used to study prostate cancer spreadfrom UPITue, 28 Apr 2009, 16:21:04 UTC
- Avodart, Prostate Drug, Found to Reduce Cancer Riskfrom NY Times HealthTue, 28 Apr 2009, 4:00:11 UTC
- Doctors urge baseline test for prostate cancerfrom PhysorgMon, 27 Apr 2009, 10:21:23 UTC
- Doctors urge baseline test for prostate cancerfrom AP HealthMon, 27 Apr 2009, 4:21:03 UTC
- Statins May Exert Influence On Prostate Cancer Growth By Reducing Inflammationfrom Science DailySun, 26 Apr 2009, 20:57:36 UTC
- Major Statin Study Reveals Several Important Findings For Reducing Prostate Cancer And Diseasefrom Science DailySun, 26 Apr 2009, 20:57:35 UTC
- Suppressor Of Cytokine Signaling (SOCS)-1 Inhibits Prostate Cancer Growthfrom Science DailySun, 26 Apr 2009, 20:57:29 UTC
- Vitamin E, selenium and soy in combination does not prevent prostate cancerfrom PhysorgSun, 26 Apr 2009, 16:56:10 UTC
- Vitamin E, Selenium And Soy In Combination Does Not Prevent Prostate Cancerfrom Science DailySun, 26 Apr 2009, 13:21:57 UTC
- Men Treated For Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumptionfrom Science DailySun, 26 Apr 2009, 13:21:55 UTC
- Statins May Exert Influence On Prostate Cancer Growth By Reducing Inflammationfrom Science DailySun, 26 Apr 2009, 13:21:41 UTC
- Major Statin Study Reveals Several Important Findings For Reducing Prostate Cancer And Diseasefrom Science DailySun, 26 Apr 2009, 13:21:38 UTC
- Suppressor Of Cytokine Signaling (SOCS)-1 Inhibits Prostate Cancer Growthfrom Science DailySun, 26 Apr 2009, 13:21:30 UTC
- Statins may exert influence on prostate cancer growth by reducing inflammationfrom Science BlogSun, 26 Apr 2009, 5:35:24 UTC
- MRI: Effective tool for determining pathologic stage of prostate cancerfrom Science BlogThu, 23 Apr 2009, 16:35:21 UTC
- Potential genetic prostate cancer variation foundfrom PhysorgTue, 21 Apr 2009, 12:28:06 UTC
- Designer immune cells fight prostate cancerfrom News @ NatureMon, 20 Apr 2009, 20:14:31 UTC
- Autopsy study links prostate cancer to single rogue cellfrom Biology News NetSat, 18 Apr 2009, 17:07:17 UTC
- Autopsy Study Links Prostate Cancer To Single Rogue Cellfrom Science DailySat, 18 Apr 2009, 1:35:50 UTC
- Autopsy study links prostate cancer to single rogue cellfrom Science BlogFri, 17 Apr 2009, 21:49:22 UTC
- Autopsy study links prostate cancer to single rogue cellfrom PhysorgFri, 17 Apr 2009, 21:28:10 UTC
- Gene Fusion Discovery May Lead To Improved Prostate Cancer Testfrom Science DailyThu, 16 Apr 2009, 1:35:10 UTC
- Company says prostate cancer vaccine shows promisefrom PhysorgTue, 14 Apr 2009, 15:42:31 UTC
- Company says prostate cancer vaccine shows promisefrom AP HealthTue, 14 Apr 2009, 15:21:26 UTC
- Promising Test for Dendreon’s Prostate Cancer Drugfrom NY Times HealthTue, 14 Apr 2009, 14:56:10 UTC
- Potential New Target For Treatment Of Hormone Refractory Prostate Cancerfrom Science DailyTue, 14 Apr 2009, 2:28:30 UTC
- Drug Shows Activity In Men With Advanced Prostate Cancerfrom Science DailyMon, 13 Apr 2009, 13:21:32 UTC
- New Drug Shows Promise In Treating Drug-resistant Prostate Cancerfrom Science DailySat, 11 Apr 2009, 4:07:20 UTC
- New drug shows promise in treating drug-resistant prostate cancerfrom Science BlogFri, 10 Apr 2009, 14:35:06 UTC
- Gene fusion discovery may lead to improved prostate cancer testfrom Science BlogThu, 9 Apr 2009, 21:42:19 UTC
- Gene fusion discovery may lead to improved prostate cancer testfrom PhysorgThu, 9 Apr 2009, 21:21:13 UTC
- New prostate cancer drugs show promisefrom UPIWed, 8 Apr 2009, 19:14:12 UTC
- A New Tool for Battling Prostate Cancerfrom Science NOWTue, 7 Apr 2009, 22:28:04 UTC
- Prostate drug shows promise in early testingfrom PhysorgTue, 7 Apr 2009, 21:56:20 UTC
- Experimental prostate cancer drug shows promisefrom CBC: HealthTue, 7 Apr 2009, 21:21:15 UTC
- New medications show promise in treating drug-resistant prostate cancerfrom Science BlogTue, 7 Apr 2009, 20:49:23 UTC
- Prostate drug shows promise in early testingfrom AP HealthTue, 7 Apr 2009, 19:28:05 UTC
- Drug trial gives hope of longer life to women fighting ovarian cancerfrom The Guardian - ScienceTue, 7 Apr 2009, 7:42:37 UTC
- A potential new target for treatment of hormone refractory prostate cancerfrom PhysorgMon, 6 Apr 2009, 18:42:09 UTC
- A potential new target for treatment of hormone refractory prostate cancerfrom Science BlogMon, 6 Apr 2009, 16:49:04 UTC
- New Marker For Prostate Cancer Progressionfrom Science DailyThu, 2 Apr 2009, 16:21:24 UTC